Eintrag weiter verarbeiten
Current Issues in the Management of Genital Herpes
Gespeichert in:
Zeitschriftentitel: | Antiviral Chemistry and Chemotherapy |
---|---|
Personen und Körperschaften: | |
In: | Antiviral Chemistry and Chemotherapy, 6, 1995, 6_suppl, S. 3-6 |
Format: | E-Article |
Sprache: | Englisch |
veröffentlicht: |
SAGE Publications
|
Schlagwörter: |
author_facet |
Barton, S. E. Barton, S. E. |
---|---|
author |
Barton, S. E. |
spellingShingle |
Barton, S. E. Antiviral Chemistry and Chemotherapy Current Issues in the Management of Genital Herpes Psychiatry and Mental health Neuropsychology and Physiological Psychology |
author_sort |
barton, s. e. |
spelling |
Barton, S. E. 2040-2066 2040-2066 SAGE Publications Psychiatry and Mental health Neuropsychology and Physiological Psychology http://dx.doi.org/10.1177/09563202950060s602 <jats:p> Genital infection by herpes simplex virus (HSV) produces a variety of clinical manifestations, patient presentations and management problems which differ in their severity and complexity. In the UK the currently available data for the incidence of genital HSV have been provided predominantly by the KC60 returns from diagnoses made in genitourinary (GU) medicine clinics. The increasing availability and recent publication of the first results, using HSV type-specific antibody tests within GU and non-GU patient populations, provide a tool to monitor trends in the epidemiology of HSV. It is, however, important to understand that the sexual behaviour which leads to this infection is variable and not necessarily general. </jats:p><jats:p> The clinical availability of type-specific HSV antibody tests also gives rise to the possibility of screening individuals and informing those who test positive of their, previously undiagnosed, condition. The practicalities and problems of this approach need to be fully assessed. The possibility of uncovering previously undiagnosed cases through general practitioners is being considered, first, in terms of surveys of the general practitioners' management of genital HSV and, secondly, because the funding of health care in the UK has put the cost-effectiveness in GU medicine clinics under the spotlight. This paper will explore the new developments in the management of genital HSV and suggests adherence to the clear principles of diagnosis and treatment that is in the patient's best interest. This has the clear aim of improving the patient's quality of life, a factor which must remain paramount as new technologies, healthcare strategies and therapies become available. </jats:p> Current Issues in the Management of Genital Herpes Antiviral Chemistry and Chemotherapy |
doi_str_mv |
10.1177/09563202950060s602 |
facet_avail |
Online Free |
finc_class_facet |
Medizin Psychologie |
format |
ElectronicArticle |
fullrecord |
blob:ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTE3Ny8wOTU2MzIwMjk1MDA2MHM2MDI |
id |
ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTE3Ny8wOTU2MzIwMjk1MDA2MHM2MDI |
institution |
DE-Gla1 DE-Zi4 DE-15 DE-Pl11 DE-Rs1 DE-105 DE-14 DE-Ch1 DE-L229 DE-D275 DE-Bn3 DE-Brt1 DE-D161 DE-Zwi2 |
imprint |
SAGE Publications, 1995 |
imprint_str_mv |
SAGE Publications, 1995 |
issn |
2040-2066 |
issn_str_mv |
2040-2066 |
language |
English |
mega_collection |
SAGE Publications (CrossRef) |
match_str |
barton1995currentissuesinthemanagementofgenitalherpes |
publishDateSort |
1995 |
publisher |
SAGE Publications |
recordtype |
ai |
record_format |
ai |
series |
Antiviral Chemistry and Chemotherapy |
source_id |
49 |
title |
Current Issues in the Management of Genital Herpes |
title_unstemmed |
Current Issues in the Management of Genital Herpes |
title_full |
Current Issues in the Management of Genital Herpes |
title_fullStr |
Current Issues in the Management of Genital Herpes |
title_full_unstemmed |
Current Issues in the Management of Genital Herpes |
title_short |
Current Issues in the Management of Genital Herpes |
title_sort |
current issues in the management of genital herpes |
topic |
Psychiatry and Mental health Neuropsychology and Physiological Psychology |
url |
http://dx.doi.org/10.1177/09563202950060s602 |
publishDate |
1995 |
physical |
3-6 |
description |
<jats:p> Genital infection by herpes simplex virus (HSV) produces a variety of clinical manifestations, patient presentations and management problems which differ in their severity and complexity. In the UK the currently available data for the incidence of genital HSV have been provided predominantly by the KC60 returns from diagnoses made in genitourinary (GU) medicine clinics. The increasing availability and recent publication of the first results, using HSV type-specific antibody tests within GU and non-GU patient populations, provide a tool to monitor trends in the epidemiology of HSV. It is, however, important to understand that the sexual behaviour which leads to this infection is variable and not necessarily general. </jats:p><jats:p> The clinical availability of type-specific HSV antibody tests also gives rise to the possibility of screening individuals and informing those who test positive of their, previously undiagnosed, condition. The practicalities and problems of this approach need to be fully assessed. The possibility of uncovering previously undiagnosed cases through general practitioners is being considered, first, in terms of surveys of the general practitioners' management of genital HSV and, secondly, because the funding of health care in the UK has put the cost-effectiveness in GU medicine clinics under the spotlight. This paper will explore the new developments in the management of genital HSV and suggests adherence to the clear principles of diagnosis and treatment that is in the patient's best interest. This has the clear aim of improving the patient's quality of life, a factor which must remain paramount as new technologies, healthcare strategies and therapies become available. </jats:p> |
container_issue |
6_suppl |
container_start_page |
3 |
container_title |
Antiviral Chemistry and Chemotherapy |
container_volume |
6 |
format_de105 |
Article, E-Article |
format_de14 |
Article, E-Article |
format_de15 |
Article, E-Article |
format_de520 |
Article, E-Article |
format_de540 |
Article, E-Article |
format_dech1 |
Article, E-Article |
format_ded117 |
Article, E-Article |
format_degla1 |
E-Article |
format_del152 |
Buch |
format_del189 |
Article, E-Article |
format_dezi4 |
Article |
format_dezwi2 |
Article, E-Article |
format_finc |
Article, E-Article |
format_nrw |
Article, E-Article |
_version_ |
1792326031486484488 |
geogr_code |
not assigned |
last_indexed |
2024-03-01T12:15:01.524Z |
geogr_code_person |
not assigned |
openURL |
url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=Current+Issues+in+the+Management+of+Genital+Herpes&rft.date=1995-12-01&genre=article&issn=2040-2066&volume=6&issue=6_suppl&spage=3&epage=6&pages=3-6&jtitle=Antiviral+Chemistry+and+Chemotherapy&atitle=Current+Issues+in+the+Management+of+Genital+Herpes&aulast=Barton&aufirst=S.+E.&rft_id=info%3Adoi%2F10.1177%2F09563202950060s602&rft.language%5B0%5D=eng |
SOLR | |
_version_ | 1792326031486484488 |
author | Barton, S. E. |
author_facet | Barton, S. E., Barton, S. E. |
author_sort | barton, s. e. |
container_issue | 6_suppl |
container_start_page | 3 |
container_title | Antiviral Chemistry and Chemotherapy |
container_volume | 6 |
description | <jats:p> Genital infection by herpes simplex virus (HSV) produces a variety of clinical manifestations, patient presentations and management problems which differ in their severity and complexity. In the UK the currently available data for the incidence of genital HSV have been provided predominantly by the KC60 returns from diagnoses made in genitourinary (GU) medicine clinics. The increasing availability and recent publication of the first results, using HSV type-specific antibody tests within GU and non-GU patient populations, provide a tool to monitor trends in the epidemiology of HSV. It is, however, important to understand that the sexual behaviour which leads to this infection is variable and not necessarily general. </jats:p><jats:p> The clinical availability of type-specific HSV antibody tests also gives rise to the possibility of screening individuals and informing those who test positive of their, previously undiagnosed, condition. The practicalities and problems of this approach need to be fully assessed. The possibility of uncovering previously undiagnosed cases through general practitioners is being considered, first, in terms of surveys of the general practitioners' management of genital HSV and, secondly, because the funding of health care in the UK has put the cost-effectiveness in GU medicine clinics under the spotlight. This paper will explore the new developments in the management of genital HSV and suggests adherence to the clear principles of diagnosis and treatment that is in the patient's best interest. This has the clear aim of improving the patient's quality of life, a factor which must remain paramount as new technologies, healthcare strategies and therapies become available. </jats:p> |
doi_str_mv | 10.1177/09563202950060s602 |
facet_avail | Online, Free |
finc_class_facet | Medizin, Psychologie |
format | ElectronicArticle |
format_de105 | Article, E-Article |
format_de14 | Article, E-Article |
format_de15 | Article, E-Article |
format_de520 | Article, E-Article |
format_de540 | Article, E-Article |
format_dech1 | Article, E-Article |
format_ded117 | Article, E-Article |
format_degla1 | E-Article |
format_del152 | Buch |
format_del189 | Article, E-Article |
format_dezi4 | Article |
format_dezwi2 | Article, E-Article |
format_finc | Article, E-Article |
format_nrw | Article, E-Article |
geogr_code | not assigned |
geogr_code_person | not assigned |
id | ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTE3Ny8wOTU2MzIwMjk1MDA2MHM2MDI |
imprint | SAGE Publications, 1995 |
imprint_str_mv | SAGE Publications, 1995 |
institution | DE-Gla1, DE-Zi4, DE-15, DE-Pl11, DE-Rs1, DE-105, DE-14, DE-Ch1, DE-L229, DE-D275, DE-Bn3, DE-Brt1, DE-D161, DE-Zwi2 |
issn | 2040-2066 |
issn_str_mv | 2040-2066 |
language | English |
last_indexed | 2024-03-01T12:15:01.524Z |
match_str | barton1995currentissuesinthemanagementofgenitalherpes |
mega_collection | SAGE Publications (CrossRef) |
physical | 3-6 |
publishDate | 1995 |
publishDateSort | 1995 |
publisher | SAGE Publications |
record_format | ai |
recordtype | ai |
series | Antiviral Chemistry and Chemotherapy |
source_id | 49 |
spelling | Barton, S. E. 2040-2066 2040-2066 SAGE Publications Psychiatry and Mental health Neuropsychology and Physiological Psychology http://dx.doi.org/10.1177/09563202950060s602 <jats:p> Genital infection by herpes simplex virus (HSV) produces a variety of clinical manifestations, patient presentations and management problems which differ in their severity and complexity. In the UK the currently available data for the incidence of genital HSV have been provided predominantly by the KC60 returns from diagnoses made in genitourinary (GU) medicine clinics. The increasing availability and recent publication of the first results, using HSV type-specific antibody tests within GU and non-GU patient populations, provide a tool to monitor trends in the epidemiology of HSV. It is, however, important to understand that the sexual behaviour which leads to this infection is variable and not necessarily general. </jats:p><jats:p> The clinical availability of type-specific HSV antibody tests also gives rise to the possibility of screening individuals and informing those who test positive of their, previously undiagnosed, condition. The practicalities and problems of this approach need to be fully assessed. The possibility of uncovering previously undiagnosed cases through general practitioners is being considered, first, in terms of surveys of the general practitioners' management of genital HSV and, secondly, because the funding of health care in the UK has put the cost-effectiveness in GU medicine clinics under the spotlight. This paper will explore the new developments in the management of genital HSV and suggests adherence to the clear principles of diagnosis and treatment that is in the patient's best interest. This has the clear aim of improving the patient's quality of life, a factor which must remain paramount as new technologies, healthcare strategies and therapies become available. </jats:p> Current Issues in the Management of Genital Herpes Antiviral Chemistry and Chemotherapy |
spellingShingle | Barton, S. E., Antiviral Chemistry and Chemotherapy, Current Issues in the Management of Genital Herpes, Psychiatry and Mental health, Neuropsychology and Physiological Psychology |
title | Current Issues in the Management of Genital Herpes |
title_full | Current Issues in the Management of Genital Herpes |
title_fullStr | Current Issues in the Management of Genital Herpes |
title_full_unstemmed | Current Issues in the Management of Genital Herpes |
title_short | Current Issues in the Management of Genital Herpes |
title_sort | current issues in the management of genital herpes |
title_unstemmed | Current Issues in the Management of Genital Herpes |
topic | Psychiatry and Mental health, Neuropsychology and Physiological Psychology |
url | http://dx.doi.org/10.1177/09563202950060s602 |